北京招聘

Primary Function:

Develop, perform and interpret in vitro immunology and/or oncology assays to support antibody lead and candidate selection.

Major Responsibilities and Duties:

1. Align with the overall goals of the team and support multiple project-relevant area.
2. Evaluate the bioactivity of molecules and elucidate the mechanism by performing required molecular and cellular a says.
3. Support the biology team on the culture, maintenance and characterization of mammalian cells for project-related molecule interaction and function study.
4. Establish cell-based function assays based on readouts including proliferation, differentiation, cytotoxicity, activation, flow cytometry, mRNA expression, etc. with human and mouse primary or engineered cells.
5. Manage external CROs to execute experiments, supervise and monitor CRO activities to ensure the study and data quality.
6. Explore new experimental techniques for the establishment of assay platform for lead characterization.
7. Interpret, analyze results and trouble-shooting.
8. Present data to discovery team.

Qualifications:

1. Ph.D. with 0-2 years of experience, Master with 2-5 years of experience in relevant area of research.
2. Background knowledge in Immune-Oncology is mandatory.
3. Expertise with flow cytometry, cytokine release, cytotoxicity and proliferation assays is strongly preferred.
4. Previous experience in assay development and drug screening is preferred.
5. Practical experience with analysis software such as FlowJo, GraphPad Prism, Excel is a plus.
6. Excellent interpersonal skills with the ability to interact effectively with people, internally and externally, are required.
7. Detail-oriented, with excellent organizational and record-keeping skills and capability to multi-task is essential.
8. Effective written and verbal communication skills in both Chinese and English are required.

Zai Lab is an innovative biopharmaceutical company based in Zhang Jiang, Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab focus on innovation to meets the unmet medical needs. Zai has built up a strong pipeline with multiple programs on clinical stages. Zai Lab successfully listed on Nasdaq in Sep. 2017.

再鼎医药是一家总部设立于上海张江，致力于研究、开发和销售创新药物的制药企业。再鼎医药针对目前尚无良好治疗手段的疾病领域开发新药，在肿瘤、抗感染、自身免疫等方面建立了全面的产品线，服务中国和全球病患。再鼎医药于2017年9月在美国纳斯达克成功上市。